search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


A national quality registry for spondyloarthritis in daily practice in the Netherlands


- candidate number27973
- NTR NumberNTR6740
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR2-okt-2017
- Secondary IDs15-4-266 / 836042001 METC van Maastricht UMC+ / ZonMW
- Public TitleA national quality registry for spondyloarthritis in daily practice in the Netherlands
- Scientific TitleA national quality registry for spondyloarthritis in daily practice in the Netherlands
- ACRONYMSpA-Net
- hypothesisEvaluation of daily practice, improve quality of care to patients with spondyloarthritis
- Healt Condition(s) or Problem(s) studiedSpondyloarthritis, Ankylosing spondylitis, Inflammatory bowel disease, Psoriatic arthritis
- Inclusion criteriaAny patients with a diagnosis of spondyloarthritis according to his/her treating rheumatologist can be included
- Exclusion criteriaNone
- mec approval receivedno
- multicenter trialyes
- randomisedno
- group[default]
- Type[default]
- Studytypeobservational
- planned startdate 1-mei-2016
- planned closingdate
- Target number of participants1000
- InterventionsNone, daily care. Through MIJNREUMACENTRUM, a web-based patient medical file and at the same time a quality management system, patient outcome and pharmacovigilance data are prospectively gathered from spondyloarthritis patients in daily practice. These include patient reported outcomes, clinical examination and laboratory investigations.
- Primary outcomeQuality of life
- Secondary outcomeDisease activity state, work productivity
- TimepointsReal-life, collection of data at each regular visit, scheduled according to treating rheumatologist
- Trial web sitewww.dreamregistry.nl
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESDr. A. Tubergen, van
- CONTACT for SCIENTIFIC QUERIESDr. A. Tubergen, van
- Sponsor/Initiator Dr. A. van Tubergen
- Funding
(Source(s) of Monetary or Material Support)
ZonMw, Reumafonds, Abbvie, Celgene , UCB Pharma B.V., MSD, Novartis, Janssen Cilag BV, Pfizer
- PublicationsWill follow
- Brief summarySpondyloarthritis (SpA) is a chronic and potentially disabling, inflammatory rheumatic disease, which needs long term monitoring and treatment. Despite its high prevalence and substantial socioeconomic impact, information on the quality of care delivered to these patients in daily practice in the Netherlands is scarce.
The aim of SpA-Net is to provide transparency on treatment and outcome of this disease in the Netherlands. Through MIJNREUMACENTRUM, a web-based patient medical file and at the same time a quality management system, patient outcome and pharmacovigilance data will be prospectively gathered from unselected SpA patients in daily practice.
- Main changes (audit trail)
- RECORD2-okt-2017 - 28-okt-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl